RadioGel™ Profile Banner
RadioGel™ Profile
RadioGel™

@RadioGel

Followers
2,244
Following
234
Media
247
Statuses
1,244

RadioGel™ is a next-generation #cancer treatment for tumors in humans. #PRnT is currently undergoing review with the @US_FDA . A trademark brand of @VivosIncUSA

United States
Joined October 2010
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@RadioGel
RadioGel™
4 years
Markets are back open Tuesday. Until then, we're wishing all our shareholders and followers a safe long weekend; with a reflective #MartinLutherKingJr holiday Monday. #MartinLutherKingDay $RDGL
Tweet media one
9
15
101
@RadioGel
RadioGel™
3 years
We're pleased to report another #Milestone event in the commercialization of #IsoPet ® therapy. The first treatment covered by Pet Insurance will be happening today at Vista Veterinary Clinic. #Cancer #pets #petinsurance #petlives #CancerAwareness #CancerResearch #dogs $RDGL
Tweet media one
2
25
98
@RadioGel
RadioGel™
3 years
Update – #IsoPet ® #Cancer Therapy was performed on Jackie, a Staffordshire-Terrier, Lab mix #dog with a large tumor on the right paw. What is noteworthy is the Pet Parent's insurance company approved the procedure. The tumor has decreased in size & the #pet is doing well. $RDGL
Tweet media one
Tweet media two
Tweet media three
@RadioGel
RadioGel™
3 years
We're pleased to report another #Milestone event in the commercialization of #IsoPet ® therapy. The first treatment covered by Pet Insurance will be happening today at Vista Veterinary Clinic. #Cancer #pets #petinsurance #petlives #CancerAwareness #CancerResearch #dogs $RDGL
Tweet media one
2
25
98
2
17
83
@RadioGel
RadioGel™
4 years
Hard to believe one week ago was New Year's Day. In the past week we've had an increased in interest in #RadioGel ™ and Vivos. Here is a handy infographic that clearly shows the key benefits of our multi-patented device technology and how it differs in the marketplace. $RDGL
Tweet media one
2
21
81
@RadioGel
RadioGel™
6 years
We began testing #RadioGel ™ | #IsopPet ® on Skin Cancer(s) to establish the safety & effectiveness of our patented technology. Here is a list of other #Cancers that we will be working with in the near future. Happy #ColumbusDay #Cancer #CancerTreatment #CancerAwareness
Tweet media one
8
38
75
@RadioGel
RadioGel™
3 years
1). Jan 20, 2022 @HopkinsMedicine treated their first pet with #IsoPet ® therapy. Francis previously had a high-grade soft tissue sarcoma removed from his left forelimb in Nov 2021. IsoPet® was utilized to treat the surgical 'dirty' margins surrounding the treatment area.
Tweet media one
3
18
73
@RadioGel
RadioGel™
6 years
Skin #Cancer was selected as our first indication of use for #RadioGel ™ to the FDA. Proven effective in killing cancer cells; it also has notable advantages over existing therapies. The potential market in #humans is just a beginning... #CancerAwareness #savinglives #hope $rdgl
Tweet media one
10
31
71
@RadioGel
RadioGel™
6 years
In any worthwhile endeavor... the quality relationships and partners that you establish along the way; are what ultimately add to its success. Thank you to all the people and #pets that have trusted in us this far. Tomorrow is a new month. #RadioGel #IsoPet ® #CancerResearch
Tweet media one
4
27
67
@RadioGel
RadioGel™
5 months
We have a team of dedicated scientists who are passionate about a next generation cancer treatment and have made RadioGel™ their top priority. The road to IDE submission will end and saving lives will begin! #CancerResearch #Cancer @VivosIncUSA $RDGL
Tweet media one
6
20
70
@RadioGel
RadioGel™
6 months
The new site is live! @RadioGel needs to focus on human cancer (we are not approved for human cancer yet), @IsoPetForCancer is our animal cancer division and @VivosIncUSA is our corporation. It's all coming together! Thank you all for your patience! $RDGL
Tweet media one
21
24
70
@RadioGel
RadioGel™
4 years
1). We're pleased to share the latest update on Yukon from her pet parents. Yukon was treated July 24, 2020: "She continues to do well, and the tumor on her leg continues to shrink. I would say it is about 1/2 the size from the last visit and the open sore has healed.
Tweet media one
8
11
67
@RadioGel
RadioGel™
4 years
We've had a lot of interest with our pending @US_FDA Breakthrough Application for #human #Cancer treatment. However; it's important to remember RadioGel™ is readily available for #PetCancer therapy. IsoPet® therapy online application: $RDGL #petlovers
Tweet media one
12
16
67
@RadioGel
RadioGel™
6 years
Exactly 1 week from today, Dr. Mike Korenko along with University of Missouri Veterinary Health Center oncologist Dr. Charles Maitz, will be taking center stage in Louisville, Kentucky to present successful results from our Canine testing with IsoPet®. #cancertreatment #research
Tweet media one
8
28
62
@RadioGel
RadioGel™
3 years
2/2 – Conference organizers allotted him twice the normal time to present. The slide presentation employed both English and Japanese translation throughout. Participants asked many good questions, and overall, expressed strong interest in the information presented. $RDGL
2
12
65
@RadioGel
RadioGel™
4 months
RadioGel™ is now officially RadioGel®! We are registered and it's perfect timing as we prepare to submit our IDE this month! The RadioGel® division is on it's way.... #RadioGel #VivosInc #IsoPet #Cancer #CancerTreatment #PRnT $RDGL
Tweet media one
6
20
67
@RadioGel
RadioGel™
2 years
@IBHenryJ @US_FDA @VivosIncCo Thank you. Our not so ‘secret weapon’ made the final cut in the presentation; Legendary #IsoPet poster dog Moose. Now 4 years post therapy and still going strong. #cancerfree #cancersurvivor #legend $RDGL
Tweet media one
3
12
62
@RadioGel
RadioGel™
3 years
With Covid-19 restrictions easing, we're expecting to handle more #IsoPet ® treatment requests. In addition, we've been receiving interest from foreign companies with inquiries into prospective collaborative ventures regarding the potential uses of #RadioGel ™. #Cancer $RDGL
Tweet media one
0
18
60
@RadioGel
RadioGel™
6 years
We’re extremely pleased to announce that IsoPet® has been successfully administered to a second dog at the #University of Missouri. #clinicaltrials #CancerAwareness #Cancer #cancerresearch #oncology #clinicaltrial
@GNWLive
GNWLive
6 years
Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the University of $RDGL
0
1
14
0
19
58
@RadioGel
RadioGel™
6 years
We've received an overwhelming amount of support today; along with numerous questions. This short animation on the Patented @IsoPet ® | @RadioGel ™ process is worth sharing over & over. Thank you. YTTRIUM 90 RADIOGEL™ BRACHYTHERAPY DEVICE $RDGL
5
26
56
@RadioGel
RadioGel™
4 years
Animal #IsoPet ® therapy applied to a #cancer tumor begins by mixing our multi-patented Yttrium-90 HydroGel ( #RadioGel ™) with the water soluble polymer. Once injected at the markers; the tumor is destroyed over time with no collateral damage to adjacent tissue. #PetCancer $RDGL
Tweet media one
5
13
60
@RadioGel
RadioGel™
6 years
IsoPet® for treating animals uses the same technology as RadioGel™ for treating humans. The @US_FDA advised using different product names in order to avoid confusion and cross-use. #IsoPet ® #RadioGel
Tweet media one
4
26
50
@RadioGel
RadioGel™
3 years
1/2. Annie from Colorado, was one of our first post Covid-19 #pets treated at the University of Missouri @MUCVM . #IsoPet ® Therapy was performed August 5, 2021 on a soft tissue sarcoma. We enjoy sharing Pet Parent updates with our shareholders and followers. #petlives $RDGL
Tweet media one
4
12
57
@RadioGel
RadioGel™
4 years
Receiving an 'IDE' for #RadioGel ™ will allow #human clinical trials to begin. The data we’ve collected through #IsoPet ® usage will form part of the pre-submission. Our target is Q2-2021. A Breakthrough Device Approval may expedite this process. $RDGL
8
15
60
@RadioGel
RadioGel™
3 years
Let’s keep Wellness Wednesday going. #IsoPet keeps doing what some people once called impossible. From our team at Vista. “It's going well. Dr. Gobble said the Pathologist said the sample that he sent in showed no signs of Blast Cells.” Very positive! #Cancers #pets #dogs $RDGL
@RadioGel
RadioGel™
3 years
Update – #IsoPet ® #Cancer Therapy was performed on Jackie, a Staffordshire-Terrier, Lab mix #dog with a large tumor on the right paw. What is noteworthy is the Pet Parent's insurance company approved the procedure. The tumor has decreased in size & the #pet is doing well. $RDGL
Tweet media one
Tweet media two
Tweet media three
2
17
83
3
10
59
@RadioGel
RadioGel™
6 years
With the ongoing development of #RadioGel ™ | #IsoPet ® – we're following a #DeNovo #FDA path which is allowing us to redefine traditional #brachytherapy #cancertreatment for both Humans & Animals. Emerson said it perfectly. #savinglives #cancerawareness
Tweet media one
0
25
54
@RadioGel
RadioGel™
10 months
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the FDA has granted RadioGel Precision Radionuclide Therapy the designation as a Breakthrough Device.$RDGL
10
18
58
@RadioGel
RadioGel™
6 years
Vivos Inc. Announces Expanded Applications of #IsoPet ® for #Veterinary Cancer Therapy. "Essentially we can now treat ALL solid tumors in a large variety of animals." #cancertreatment #petcancers #Cancers #savinglives $rdgl |
Tweet media one
4
27
54
@RadioGel
RadioGel™
6 years
One of the most promising fields developing in #CancerResearch is 'combination therapy'. The power of synergistic treatments may be able to accomplish more than just one. #immunotherapy combined with radiation treatment has exciting possibilities. #Cancertreatment #savinglives
Tweet media one
3
17
52
@RadioGel
RadioGel™
6 years
Wow. Inspiring story. Inoperable localized brain tumors are one of the highest priority #cancers that we plan on targeting with #RadioGel . We’re exploring the #RightToTry Law on how we may become an active participant. Way to fight Natalie. #CancerResearch #CancerAwareness
@SurvivorNetTeam
SurvivorNet
6 years
"I'm still here, and I will do whatever it takes to fight." Natalie Wells has terminal brain cancer, but she's determined to stay around to raise her two young daughters. #fightcancer #cancersucks #cancerwarrior
0
3
9
2
18
55
@RadioGel
RadioGel™
2 months
This is what our team is working so hard on these past few months, we are advocating for our revolutionary cancer treatment to be approved. We will update as new information becomes available! $RDGL To learn more read the blog at
Tweet media one
3
22
57
@RadioGel
RadioGel™
6 years
We've been referencing this path in our News Releases over the past year. Treating animals first is what lead to the registered brand #IsoPet ®. It has also provided us with the critical data to move forward on another goal – Saving #human lives. Thank you.
4
12
51
@RadioGel
RadioGel™
3 years
We’re diligently working towards being one of the ‘trusted providers’ when it comes to discussing tumor treatment options. #CancerResearch #CancerTreatment $RDGL
@theNCI
National Cancer Institute
3 years
People diagnosed with rare brain and spine tumors, and researchers who study them, face unique challenges. NCI-CONNECT intends to address those challenges head on. Find out how. #NothingWillStopUs #CancerCare
Tweet media one
1
10
24
1
12
55
@RadioGel
RadioGel™
3 years
Vivos Inc. Files Early Feasibility IDE Application with @US_FDA for Radiogel™ #PressRelease #Cancer #CancerResearch $RDGL #radiogel #human #cancertreatment
9
15
55
@RadioGel
RadioGel™
3 years
We're working on it @jimcramer ! #RadioGel ™ as our Pet brand #IsoPet ® – is a proven @US_FDA cleared device for use in treating animal #cancers . #Humans are next on the list. This is the future of treating #inoperable #tumors . #CancerResearch $RDGL
@jimcramer
Jim Cramer
3 years
People are loving medical device companies as re-opening plays.. i get it. $ISRG started it.. $MDT, $EW
59
10
163
0
14
56
@RadioGel
RadioGel™
3 years
Today is an important #milestone for Vivos & reflects the efforts of numerous parties. In particular, we're pleased that this IDE filing included the Mayo Clinic Clinical Trial Protocol for #RadioGel ™, which is currently being reviewed by Mayo’s Independent Review Team. $RDGL
Tweet media one
4
16
53
@RadioGel
RadioGel™
6 years
Numerous have asked; we're answering. "An important difference of RadioGel™ to older #brachytherapy products is, the minimally invasive radiation that is emitted to adjacent healthy tissue. We have achieved a very high therapeutic index in our animal testing.
Tweet media one
2
23
51
@RadioGel
RadioGel™
6 years
What makes @RadioGel ™ unique? Our Beta emitter technology. It delivers a high dose of localized radiation that does not travel far; thus minimizing collateral damage to healthy tissue. This is in complete opposite to most other #brachytherapy products that still utilize Gamma.
Tweet media one
2
27
50
@RadioGel
RadioGel™
5 years
Great news worth sharing this Saturday morning from Facebook regarding Moose. "Hallelujah!!! No visible soft tissue sarcoma tumors! Final official report is in from 1 year since diagnosis! Clear chest Xray! Clear lymph nodes! Perfect blood work!" $RDGL
Tweet media one
5
16
53
@RadioGel
RadioGel™
7 months
We are the future of cancer treatment. You have been asking "How it works" so here it is! We are New Generation Cancer Treatment! #RadioGel #IsoPet #VivosUSA #NewGeneration #Cancer #CancerTreatment #TheFutureOfCancerTreatment #NewGeneration $RDGL
Tweet media one
1
23
55
@RadioGel
RadioGel™
2 years
It’s a #Milestone ! A three (3) year process to receive an invaluable #patent for manufacturing the hydrogel component for our #RadioGel ™ & @IsoPet_RadioGel Therapies has been achieved. Congratulations to our Team. Mike Korenko Sc. D - CEO • President Vivos, Inc. $RDGL
Tweet media one
0
17
54
@RadioGel
RadioGel™
6 years
"The 'safety' of our patented procedure is very important to us". Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the #University of Missouri. #clinicaltrials #CancerAwareness #Cancer #cancerresearch #oncology #savinglives
Tweet media one
2
16
48
@RadioGel
RadioGel™
6 years
You may have seen a @Facebook Blog setup by the owner of the 2nd canine in our trials. Pam has been gracious to track & share the progress of 'Moose'. Great to have additional feedback outside the visits to see Dr. Maitz @MUCVM #petcancerawarenessmonth |
Tweet media one
3
12
49
@RadioGel
RadioGel™
3 years
1/2 – July 8, 2021, Dr. Darrell Fisher, Vivos Inc’s medical physicist; delivered his invited paper by virtual link-up at the Japan Radioisotope Association Annual Meeting on #IsoPet therapy. The title was “Radionuclide Therapy of Solid Tumors by Direct Interstitial Injection.”
Tweet media one
4
12
52
@RadioGel
RadioGel™
5 months
What is the science behind RadioGel™ and how does Y-90 play a role in the treatment of cancer? Read the blog and subscribe to our newsletter to read the latest as we prepare to submit the IDE for RadioGel™ to be used for human cancer trials. #Cancer $RDGL
Tweet media one
2
19
54
@RadioGel
RadioGel™
6 years
October has been a busy month. It's only been a few weeks since we made crucial improvements to our financial position; in addition we presented Successful results from IsoPet® usage at 2 major #veterinary conferences. #CancerAwareness #savinglives #milestones #clinicaltrials
Tweet media one
0
12
52
@RadioGel
RadioGel™
6 months
New website means new posts dedicated to the RadioGel division of @VivosIncUSA Please follow our @IsoPetForCancer as we are already treating cancer in small and large animals, humans will be next! $RDGL #Cancer #NewGenerationCancerTreatment
Tweet media one
5
17
54
@RadioGel
RadioGel™
4 months
RadioGel™ is one of the two divisions @VivosIncUSA @IsoPetForCancer has been treating animals with cancer since 2018 and is expanding! The IDE will be submitted for human cancer trials in Q2. has the latest information $RDGL
Tweet media one
6
21
54
@RadioGel
RadioGel™
5 months
IDE Update - the team @VivosIncUSA is carefully reviewing the IDE application to submit to the FDA. An investigational device exemption (IDE) allows the device to be used in a clinical study in order to collect safety and effectiveness data. #Cancer $RDGL
Tweet media one
4
15
54
@RadioGel
RadioGel™
4 years
1/2). We're pleased to share another #IsoPet ® update on our favourite Lab, Yukon. "Yukon continues to do well. Tumor continues to shrink ! She eats well and healthy. Getting older – she will be 10 in July – so she has slowed down ... not quite as fast in frisbee toss...
Tweet media one
6
9
47
@RadioGel
RadioGel™
6 years
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet® | | #CancerResearch #Cancers #Cancer #petcancer
Tweet media one
4
14
48
@RadioGel
RadioGel™
4 years
Good day. As per our timeline review with our @US_FDA Breakthrough Device application; late yesterday $RDGL received word from the Agency for clarification on one of the Criterion. This dialogue was anticipated and we're responding accordingly before the due date. Thank you.
Tweet media one
6
12
51
@RadioGel
RadioGel™
3 years
(1/2). As part of our @FDA IDE application process the first 'pre-submission' meeting for #RadioGel ™ is scheduled for November 30, 2021. The FDA recommended this path to facilitate enhanced ongoing communication with Vivos and to increase the efficiency of the review process.
@RadioGel
RadioGel™
3 years
Today is an important #milestone for Vivos & reflects the efforts of numerous parties. In particular, we're pleased that this IDE filing included the Mayo Clinic Clinical Trial Protocol for #RadioGel ™, which is currently being reviewed by Mayo’s Independent Review Team. $RDGL
Tweet media one
4
16
53
4
7
50
@RadioGel
RadioGel™
4 years
Interesting finding. May change the way science approaches future treatments. RadioGel™ won't let those #Cancer cells hibernating in a #tumor re-awaken. "If we can reach the tumor; we can kill it." – Dr. Mike Korenko #brachytherapy #cancertreatment #CancerResearch #RadioGel
@OncologyTimes
Oncology Times
4 years
Tweet media one
0
0
0
2
16
49
@RadioGel
RadioGel™
6 years
Dr. Korenko is busy packing his bags, to begin making his way across the country to Louisville, Kentucky for the VCS Conference. He'll be speaking at 9:00 am EST Saturday, October 20th. Once again here is link to our news about attending the event. #IsoPet
Tweet media one
3
11
46
@RadioGel
RadioGel™
6 months
Lots of questions on where our website went, it was all part of the plan to have people visit our new corporate site The rebranding is a process so please be patient with us! #CancerTreatment #RadioGel #IsoPet #VivosIncUSA $RDGL
Tweet media one
2
15
52
@RadioGel
RadioGel™
4 years
Although we did not receive 'fast tracking' approval in regards to our 'Breakthrough Device" #RadioGel ™, we're performing additional testing to hit our Early Summer '21 target of submission for our IDE with the @US_FDA . $RDGL #CancerResearch #Cancer
Tweet media one
9
7
51
@RadioGel
RadioGel™
3 months
We have more information on the website at but here is a refresher on our IsoPet® and RadioGel® division @VivosIncUSA $RDGL
Tweet media one
2
19
52
@RadioGel
RadioGel™
4 years
Our primary focus in the coming New Year will be securing the Investigational Device Exemption ("IDE") from the @US_FDA for our multi-patented #RadioGel #brachytherapy device; and continue to plan for future #human clinical trials. #Cancer will be beaten. $RDGL #breakthrough
Tweet media one
1
8
47
@RadioGel
RadioGel™
3 years
Vivos Inc Obtains Feedback from the FDA on Clinical Testing of #RadioGel ™. November 30 Vivos Inc. met with the @US_FDA to obtain suggestions on improving the current draft of the IDE for #Human Clinical Trials. #Cancer #CancerTreatment $RDGL
Tweet media one
7
11
48
@RadioGel
RadioGel™
3 years
Although, we have not 'yet' saved a Human from an inoperable #Cancer tumor; we've saved our share of furry little friends. Human and #Pet lives matter to us. We're looking forward to creating many, many more Survivors. #NationalCancerSurvivorsDay #CancerSurvivors #pets $RDGL
Tweet media one
8
13
48
@RadioGel
RadioGel™
3 years
(2/2). This review typically takes several iterations and we will continue with biocompatibility testing in parallel. This filing is an important milestone for Vivos and reflects the efforts of numerous parties. We will share updates of the process when possible. Thank you.
2
3
48
@RadioGel
RadioGel™
4 years
We're pleased to announce that we've received word that our application for Breakthrough Device Designation has been accepted, and is now being processed. #FDA #Cancer #CancerResearch #Breakthough #SavingLives $RDGL
Tweet media one
10
13
48
@RadioGel
RadioGel™
4 years
We're working diligently to become an approved #brachytherapy treatment for this type of #Cancer ; and so many others. #Cancer will be beaten. #thyroidawarenessmonth #CancerAwareness #CancerResearch $RDGL
@MayoClinic
Mayo Clinic
4 years
Consumer Health: Treating thyroid cancer.
Tweet media one
1
8
35
1
10
47
@RadioGel
RadioGel™
4 years
Late today we submitted our response to the @US_FDA comments on our application for Breakthrough Device Designation for #RadioGel ™. This was a substantial effort involving our entire team and three @MayoClinic doctors working over the holidays.
Tweet media one
5
12
48
@RadioGel
RadioGel™
8 months
One of our frequently asked questions is "How does your treatment work?" Here is the short answer to our patented treatment for both humans and pets. #VivosIncUSA #PRRadioGel #IsoPet #PRnT #CancerTreatment #NewGeneration $RDGL
Tweet media one
1
21
50
@RadioGel
RadioGel™
3 years
1/2 “This effort has been substantial over the last several months, and is an invaluable investment necessary to transform our company into a serious commercial entity that has the potential to treat both animal and humans both domestically & internationally." $RDGL #RadioGel
Tweet media one
2
11
49
@RadioGel
RadioGel™
3 years
2/2). Here is the latest update from Annie's Parent: "Dear Dr. Korenko: Annie is actually doing really well! The tumor is gone now, and the wound is healing well. Here is a video of her running again." #Cancer #petlives #dogsoftwitter #dogs #dogs #CancerResearch $RDGL
1
8
48
@RadioGel
RadioGel™
4 years
Always nice to have one of our favorite Poster Ready Canine's hamming it up for the camera. Moose is still alive and kicking, and enjoying life to the fullest thanks to IsoPet®. $RDGL #petlives #dogsoftwitter #Cancer Follow his journey on Facebook at
Tweet media one
3
5
46
@RadioGel
RadioGel™
3 years
We're continually asked, "What #Cancers will your multi-patented #RadioGel #brachytherapy be able to treat." Here's our list of #Cancers our Advisory Board believe we'll be able to safely treat. #IsoPet ® is currently being applied successfully on #pet skin cancer. $RDGL
Tweet media one
6
11
47
@RadioGel
RadioGel™
7 months
Introducing our CEO Mike Korenko to our loyal followers. Dr. Korenko has a Doctor of Science from MIT, was a NATO Postdoctoral Fellow at Oxford University, and was selected as a White House Fellow for the Department of Defence. #VivosIncUSA $RDGL
Tweet media one
6
14
48
@RadioGel
RadioGel™
4 years
1/2... We're pleased to share Dr. Darrell Fisher's Peer Reviewed Article on Y-90 #IsoPet ® is the highest downloaded article in the Journal in 2020. "Direct Interstitial Treatment of Solid Tumors Using an Injectable Yttrium-90-Polymer Composite" Link:
Tweet media one
3
11
47
@RadioGel
RadioGel™
7 months
Protecting our products is a VERY important part of the growth and strength of our brand. We just added another 3 trademarks to the list! #Growth #VivosIncUSA #RadioGel #IsoPet #NewGeneration #CancerTherapy $RDGL
Tweet media one
2
14
48
@RadioGel
RadioGel™
6 years
At Conventions, posters are made to demonstrate a product, or process. Our #IsoPet ® poster is almost 5' wide; utilizing results from our recent successful #canine tests. Shortly, we'll be converting it into a slide show & placing on our website. #CancerAwareness #CancerTreatment
Tweet media one
2
13
43
@RadioGel
RadioGel™
4 years
We're receiving growing requests for #IsoPet ® Therapy throughout the US, Canada and other countries. We're working through this Covid-19 pandemic to offer more Regional accessibility to this treatment in the coming year. #Cancer #savinglives #pets #animals $RDGL
Tweet media one
2
12
47
@RadioGel
RadioGel™
2 years
We’re pleased to share an update regarding our @US_FDA IDE pre-submission process with #RadioGel ™. We’ve formally requested the next FDA meeting and submitted our proposed Animal Test Plan. Thank you. Update: #cancers #cancer #nextgeneration $RDGL
Tweet media one
0
10
41
@RadioGel
RadioGel™
8 months
A summary of our very busy and productive February! We are gearing up for an amazing March! #IsoPet #RadioGel #VivosIncUSA #Cancer #PetCancer #CancerTreatment #RoadToIDE $RDGL
Tweet media one
2
10
47
@RadioGel
RadioGel™
3 years
Happy June 1st! As we expand and intensify our search for more #Regional Animal Clinic Partners across the country, we made a long overdue 'minor tweak' to our IsoPet® logo. #petcancer #pet #veterinarian #Cancer #CancerTreatment #savinglives $RDGL
Tweet media one
3
5
47
@RadioGel
RadioGel™
4 years
Reminder... January is #ThyroidAwarenessMonth . Utilizing #RadioGel ™ device technology; we're working to have diseased Thyroids saved, versus removed. $RDGL
@MayoClinic
Mayo Clinic
4 years
January is #ThyroidAwarenessMonth . The thyroid gland is a vital hormone gland. Mayo Clinic's Thyroid Disorders Specialty Group provides comprehensive consultations for patients with thyroid disease or those with suspected thyroid disorder. @MayoClinicEndo
Tweet media one
0
21
46
2
12
45
@RadioGel
RadioGel™
6 years
"I believe that #veterinary oncologists around the Globe will finally have an ideal product line for the treatment of accessible and inoperable tumors." – Dr. Alive Villalobos | Chair of the Vivos Inc. Veterinary Medical Advisory Board #pets #cancertreatment #WorldAnimalDay
1
16
39
@RadioGel
RadioGel™
6 years
Yttrium-90 IsoPet® delivers a high does of radiation for a short period of time, and utilizing our #patented Beta Emitter technology, it's also safe for the practitioner(s) & caregiver(s) of the treated patient." #outpatient #CancerResearch #CancerTreatment #biotech #savinglives
Tweet media one
3
15
42
@RadioGel
RadioGel™
6 years
Vivos Inc. CEO Dr. Korenko's narrated slide presentation from the recent VCS Conference @theACVR Ocotber 20, 2018 in Louisville, Kentucky, may now be viewed on our website. #CancerResearch #Cancer #IsoPet ® #RadioGel #savinglives #CancerTreatment
Tweet media one
1
16
44
@RadioGel
RadioGel™
1 year
RadioGel™ is not a drug. It's a next-generation multi patented medical device that involves injecting a proprietary #yttrium -90 (90Y) gel into a solid tumor, effectively killing the #Cancer . $RDGL #CancerResearch
@VivosIncUSA
Vivos Inc.
1 year
RadioGel™ is an yttrium-90 (90Y) based injectable Precision Radionuclide Therapy (PRnT)® medical device for the treatment of cancerous tumors in animals (IsoPet®) and humans (RadioGel™). Our multi-patented Precision Radionuclide Therapy (PRnT)® uses highly localized
1
10
33
1
14
44
@RadioGel
RadioGel™
6 months
Cancer is only getting more prevalent and as technology advances, we are excited to be part of the fight against cancer. We are dedicated to saving lives worldwide! The future is coming and we will be ready! #VivosIncUSA #RadioGel #IsoPet #Cancer $RDGL
Tweet media one
0
22
46
@RadioGel
RadioGel™
4 years
More #IsoPet updates: "Yukon's tumor continues to get smaller. The open sore has healed. She is doing well – appetite and activity both good. Thanks again – Happy Holidays and continued success with the clinical trials!" Steve & Kathy (Pet Parents). $RDGL #pets #dogs #cancerfree
Tweet media one
1
11
44
@RadioGel
RadioGel™
4 years
For those new to #RadioGel ™ | #Isopet ®; here is a brief presentation of the #breakthrough science & #Biotechnology behind our international multi-patented #brachytherapy medical-device. #CancerResearch #Cancer #CancerTreatment #savinglives $RDGL #RDGL
3
7
43
@RadioGel
RadioGel™
4 years
... pre-submission meeting so we can now move ahead to the next level of review. With all the criticism directed toward the @US_FDA I have to say they have done an excellent job in helping us navigate this process and focus our efforts. Thank you. Dr. M Korenko. $RDGL
0
3
43
@RadioGel
RadioGel™
3 years
Our first #horse #IsoPet ® therapy was performed last year on Summer Solstice. Here are some before and after photos of the #Cancer and the completely healed area. Yes. #RadioGel ™ does what it's designed to do. #equine #cancersurvivor #animals $RDGL
Tweet media one
Tweet media two
Tweet media three
2
8
44
@RadioGel
RadioGel™
4 years
Dr. Korenko and our team have been diligently working to improve #RadioGel through continual testing so that we can be one of these ‘exciting new technologies’ in the marketplace. $RDGL #Cancer #CancerResearch #savinglives
@theNCI
National Cancer Institute
4 years
"We've seen consistent and meaningful declines in cancer mortality, and exciting new technologies, across the spectrum from prevention to diagnosis to survivorship." #AACR21
5
5
13
5
9
44
@RadioGel
RadioGel™
6 years
Wow. One just had to look at that Ballpark this evening to see we've all been affected in someway by #Cancer ...our Team included. We have a lot of desire to bringing our treatment(s) to patients worldwide. If we can reach the #Tumor ; we can kill it. #savinglives #CancerResearch
@SU2C
Stand Up To Cancer
6 years
Another touching placard moment during tonight’s #WorldSeries game where thousands held placards to share who they stand up for. Help us reach our goal of $15,000 to help create a world with more long-term survivors. Donate here: .
Tweet media one
Tweet media two
Tweet media three
Tweet media four
6
67
210
1
13
41
@RadioGel
RadioGel™
4 years
Numerous highlights in today's Annual Recap & Outline by Vivos, Inc. CEO & President Dr. Mike Korenko. We've planned for a productive 2021. Release: #radiogel #CancerResearch #cancertreatment #Cancers #Human #Cancer #brachytherapy #Biotechnology $RDGL
Tweet media one
5
8
43
@RadioGel
RadioGel™
6 years
Our second #canine treated with #IsoPet ® is still responding very well to treatment received late last Fall. If you’re on Facebook, you can follow the owners detailed blog. #cancersurvivor #petcancer #cancerawareness #CancerResearch
Tweet media one
2
9
40
@RadioGel
RadioGel™
4 years
This past year we selected one of the largest medical isotope suppliers in the world, Eckert & Zieglar Radiopharma () for Yttrium-90 (Y-90) utilized in our multi-patented formalization of #RadioGel ™ | #IsoPet ® #brachytherapy . $RDGL #Cancer #Biotechnology
Tweet media one
4
11
40
@RadioGel
RadioGel™
4 years
Just a reminder this week Vivos Inc. CEO & President Dr. Mike Korenko will be providing his Annual Update: 2020 Recap and Outlining 2021 Objectives. Stay tuned. #radiogel #isopet #CancerResearch #cancertreatment #Cancers #pets #petcancers #petlovers #pet #human #Cancer $RDGL
Tweet media one
0
11
43
@RadioGel
RadioGel™
5 months
As we ramp up to open the RadioGel™️ division @VivosIncUSA this study connects why our @IsoPetForCancer division is so important. We are saving pets with our cutting edge #cancer treatment and humans will be next! $RDGL
Tweet media one
2
15
44